KalVista (KALV) CMO exercises 6,250 RSUs and sells shares to cover taxes
Rhea-AI Filing Summary
KalVista Pharmaceuticals Chief Medical Officer Paul K. Audhya reported routine equity compensation-related transactions. On May 21, 2026, he exercised 6,250 restricted stock units (RSUs), receiving 6,250 shares of Common Stock at $0.00 per share upon settlement.
On May 22, 2026, he sold 2,685 Common Stock shares at an average price of $26.7844 per share solely to cover tax withholding obligations through a "sell to cover" transaction, which the filing states was not a discretionary sale. After these transactions, he directly owned 147,499 Common Stock shares and 68,750 RSUs representing contingent rights to receive an equal number of shares over time, subject to vesting.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 2,685 shares ($71,916)
Net Sell
3 txns
Insider
Audhya Paul K.
Role
CHIEF MEDICAL OFFICER
Sold
2,685 shs ($72K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,685 | $26.7844 | $72K |
| Exercise | Restricted Stock Unit | 6,250 | $0.00 | -- |
| Exercise | Common Stock | 6,250 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 147,499 shares (Direct);
Restricted Stock Unit — 68,750 shares (Direct)
Footnotes (1)
- Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. 1/16th of the total restricted stock units subject to the Award shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on May 21, 2025, subject to continued service through each vesting date.
Key Figures
Shares sold: 2,685 shares
Sale price: $26.7844 per share
RSUs exercised: 6,250 units
+2 more
5 metrics
Shares sold
2,685 shares
Common Stock sold on May 22, 2026 to cover taxes
Sale price
$26.7844 per share
Average price for 2,685 Common Stock shares sold
RSUs exercised
6,250 units
Restricted Stock Units converted to Common Stock on May 21, 2026
Shares held after
147,499 shares
Direct Common Stock ownership following reported transactions
RSUs outstanding
68,750 units
Restricted Stock Units remaining after 6,250-unit conversion
Key Terms
Restricted Stock Unit, RSU, sell to cover, Vesting Commencement Date
4 terms
Restricted Stock Unit financial
"Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
RSU financial
"Each restricted stock unit ("RSU") represents a contingent right to receive 1 share"
Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.
sell to cover financial
"sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction"
Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.
Vesting Commencement Date financial
"shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on May 21, 2025"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did KalVista (KALV) CMO Paul K. Audhya report?
Paul K. Audhya reported exercising 6,250 restricted stock units into Common Stock and selling 2,685 shares. The exercise was at no cost per share, and the sale was executed to cover tax withholding obligations associated with the RSU vesting and settlement.
What RSU activity did the KalVista (KALV) filing disclose for the CMO?
The filing shows 6,250 restricted stock units were converted into Common Stock on May 21, 2026 at $0.00 per share upon settlement. It also notes a remaining RSU balance of 68,750 units, subject to quarterly vesting starting on May 21, 2025, contingent on continued service.